Dunhill Financial’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
Other funds holding FATE
Dunhill Financial's FATE Position: Q3 2026 in Review
Dunhill Financial reduced its Fate Therapeutics (FATE) stake by 100% in Q3 2026, selling an estimated $8.22K and leaving 2 shares worth $7.54K. The position accounts for ﹤0.01% of the portfolio, ranked #658.
Dunhill Financial first reported a position in FATE in Q4 2023 and has held it in 12 quarters since. The position peaked at $23.3K in Q1 2024. 142 funds tracked by Wall St. Rank hold FATE as of Q3 2026.
- Dunhill Financial held 2 shares of Fate Therapeutics worth $7.54K as of Q3 2026.
- Dunhill Financial sold 3,178 Fate Therapeutics shares in Q3 2026, an estimated $8.22K.
- Fate Therapeutics made up ﹤0.01% of Dunhill Financial's portfolio in Q3 2026, its #658 holding.
- Dunhill Financial first reported a position in Fate Therapeutics in Q4 2023 and has held it in 12 quarters since.
- Dunhill Financial's Fate Therapeutics position peaked at $23.3K in Q1 2024.
- 142 funds tracked by Wall St. Rank held Fate Therapeutics as of Q3 2026.
Based on Dunhill Financial's 13F filing for Q3 2026, filed 16 Nov 2026.